Creating Meaning Following Cancer: An Intervention to Improve Existential and Global Quality of Life
1 other identifier
interventional
513
1 country
6
Brief Summary
The purpose of this study is to test the efficacy of a cognitive-existential intervention (using either an individual or a group format) to improve the existential and global quality of life of patients as compared to usual care in a population of adult non-metastatic cancer patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Feb 2009
Longer than P75 for not_applicable
6 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2009
CompletedFirst Submitted
Initial submission to the registry
June 9, 2010
CompletedFirst Posted
Study publicly available on registry
June 11, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2018
CompletedMarch 6, 2018
March 1, 2018
4.8 years
June 9, 2010
March 2, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (6)
Existential quality of life
At every time frame, we use two questionnaires to measure the primary outcome: 1. The McGill Quality of Life Questionnaire (MQOL): 16 items plus a single-item global scale. 2. Spiritual well-being (FACIT-SP): The FACIT-SP is a sub-scale of the FACT-G (Functional Assessment of Cancer Therapy-General) and a French version of the "FACIT-SP, FACIT-Spiritual well-being scale". This questionnaire has two sub-scales: Meaning/Peace (8 items) and Faith (4 items).
T0: Pre-intervention
Existential quality of life
T1: Mid-intervention (6 weeks after the beginning of the intervention)
Existential quality of life
T2: End of the intervention (12 weeks after the beginning of the intervention)
Existential quality of life
T3: First follow-up measure (3 months after the end of the intervention)
Existential quality of life
T4: Second follow-up measure (6 months after the end of the intervention)
Existential quality of life
T5: Last follow-up measure (12 months after the end of the intervention)
Secondary Outcomes (6)
Global quality of life
T0: Pre-intervention
Global quality of life
T1: Mid-intervention (6 weeks after the beginning of the intervention)
Global quality of life
T2: End of the intervention (12 weeks after the beginning of the intervention)
Global quality of life
T3: First follow-up measure (3 months after the end of the intervention)
Global quality of life
T4: Second follow-up measure (6 months after the end of the intervention)
- +1 more secondary outcomes
Study Arms (3)
Usual care
OTHERSubjects in this group receive the usual treatment only.
Individual intervention
EXPERIMENTALConsisting in a 12 weekly sessions with a therapist. Each session lasts 1 hour.
Group intervention
EXPERIMENTALConsisting in a 12 weekly sessions with two therapists. Number of subjects in each group is from 5 to 10. Each session lasts 2 hours.
Interventions
Over the past 2 years we developed a 12-week cognitive-existential intervention consisting of 12 modules. The first three modules essentially involve cognitive and behavioral techniques proposing reinforcement of the use of active behavioral (e.g., relaxation, activation) and emotional (cognitive reframing) strategies. This content comes from classical cognitive-behavioral techniques. The next 3 modules, inspired by empirically-tested interventions further explore emotional strategies. The last six modules specifically address the existential dimension. They are adapted from logotherapy techniques, which are also empirically-based, and have been adapted to a French-Canadian culture by our team. They aim to improve meaning-based and emotional coping strategies.
Eligibility Criteria
You may qualify if:
- Be of 18 years of age or more;
- Speak French;
- Have received a diagnosis of non-metastatic cancer;
- Be available to participate in the program of 12 weekly group or individual sessions.
You may not qualify if:
- Depressive mood (score greater than 10 on the Hospital Anxiety and Depression Scale depressive subscale) that could interfere with the intervention. Since we specifically target the existential dimension and it might temporarily provoke questioning in patients, high psychological distress must first be addressed using other approaches.
- Diagnosis of metastatic cancer or diagnosis of non-metastatic cancer with a usually fast-growing and unpredictable course, making it unlikely to adhere to the intervention (e.g., pancreatic cancer, acute leukemia, glioblastoma).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- CHU de Quebec-Universite Lavallead
- Laval Universitycollaborator
- Centre de recherche en cancérologie de l'Université Lavalcollaborator
- Canadian Cancer Society (CCS)collaborator
- Maison Michel-Sarrazincollaborator
Study Sites (6)
University of Manitoba
Winnipeg, Manitoba, R3T 2N2, Canada
Centre hospitalier affilié universitaire de l'Hôtel-Dieu de Lévis
Lévis, Quebec, G6V 3Z1, Canada
McGill University
Montreal, Quebec, H3A 2T5, Canada
CHU de Québec - Université Laval
Québec, G1R2J6, Canada
CHU de Québec - Université Laval
Québec, G1S 4L8, Canada
Institut universitaire de cardiologie et de pneumologie de Québec
Québec, G1V 4G5, Canada
Related Publications (2)
Gagnon, P., Fillion, L., Girard, M.La recherche de sens à la suite d'un diagnostic de cancer: une invervention pour améliorer la qualité de vie existentielle et globale.Les cahiers francophones de soins palliatifs 9 (1): 57-69, 2008.
BACKGROUNDGagnon P, Fillion L, Robitaille MA, Girard M, Tardif F, Cochrane JP, Le Moignan Moreau J, Breitbart W. A cognitive-existential intervention to improve existential and global quality of life in cancer patients: A pilot study. Palliat Support Care. 2015 Aug;13(4):981-90. doi: 10.1017/S147895151400073X. Epub 2014 Jul 22.
PMID: 25050872BACKGROUND
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Pierre Gagnon, MD, FRCPC
Laval University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- FACTORIAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD, FRCPC, Psychiatrist
Study Record Dates
First Submitted
June 9, 2010
First Posted
June 11, 2010
Study Start
February 1, 2009
Primary Completion
December 1, 2013
Study Completion
August 1, 2018
Last Updated
March 6, 2018
Record last verified: 2018-03